(Hypertension. 2001;37:687.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
From the Second Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan, and the Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pa (A.F.S.).
Correspondence to Dr Alan F. Sved, 446 Crawford Hall, University of Pittsburgh, Pittsburgh, PA 15260. E-mail: sved{at}pitt.edu
| Abstract |
|---|
|
|
|---|
Key Words: brain stem glutamic acid kynurenic acid hypertension
| Introduction |
|---|
|
|
|---|
Despite the importance of the tonic activity of RVLM neurons to the maintenance of baseline AP, the mechanisms maintaining the activity of RVLM vasomotor neurons are incompletely understood. Injections of excitatory amino acid (EAA) receptor antagonists into the RVLM fail to alter baseline AP,2 3 4 suggesting that inputs to the RVLM using EAA neurotransmitters are not involved in generating the tonic activity of RVLM vasomotor neurons. However, on the basis of our observation that after the removal of inhibitory inputs to the RVLM, injection of the EAA receptor antagonist kynurenic acid (KYN) into the RVLM greatly reduces AP,4 we suggested that tonically active EAA inputs to the RVLM do contribute to the activity of RVLM vasomotor neurons, although this excitatory influence is normally balanced by EAA-mediated inputs that drive an inhibitory influence on RVLM vasomotor neurons.
On the basis of our model of tonically active EAA-mediated excitatory and inhibitory influences on RVLM vasomotor neurons, we proposed that shifts in the balance of these excitatory and inhibitory influences would affect baseline AP and that a shift toward excitation could result in increased activity of RVLM neurons and a sustained increase in AP. In support of this notion, we recently reported that injecting KYN into the RVLM of spontaneously hypertensive rats restores AP to normotensive levels.5 Similarly, KYN injected into the RVLM reportedly decreases AP in renal hypertensive rats.6 Thus, hypertension in these animal models may result from an imbalance of the EAA-driven excitatory and inhibitory influences on RVLM vasomotor neurons, causing relatively more excitation than inhibition.
High dietary salt may also alter the regulation of RVLM
vasomotor neurons. Pawloski-Dahm and
Gordon7 demonstrated that
rats that had an increased consumption of NaCl showed exaggerated
pressor responses to the injection of the EAA glutamate into the RVLM.
We confirmed this observation and also showed that other excitatory
substances injected into the RVLM result in an enhanced pressor
response in rats fed a diet containing 8% NaCl compared with 1%
NaCl.8 Despite the increased
pressor responses elicited by the excitation of the RVLM, increased
dietary salt intake does not increase AP in otherwise normal rats. We
suggested that this lack of an effect of NaCl on AP results from
potentiated inhibitory and excitatory influences on the
RVLM.8 Consistent
with this notion, we observed enhanced depressor responses in response
to the injection of
-aminobutyric acid into the RVLM in rats
fed a diet containing 8% NaCl (Madden and Sved, unpublished
observations, 2000).
On the basis of the hypotheses that hypertension can result from an imbalance of excitatory and inhibitory influences on the RVLM driven tonically by EAA-mediated inputs to the RVLM and that elevated dietary salt intake enhances both excitatory and inhibitory influences on RVLM vasomotor neurons, we further hypothesize that salt-sensitive hypertension may be due to unequal potentiation of these excitatory and inhibitory influences on the RVLM. The present study begins to test this hypothesis using the Dahl model of salt-sensitive hypertension.9 This hypothesis predicts that the injection of KYN into the RVLM would not alter AP in Dahl salt-resistant (DR) rats, whereas it would decrease AP in Dahl salt-sensitive (DS) rats on a high-salt diet.
| Methods |
|---|
|
|
|---|
Rats were anesthetized with halothane and prepared
for measuring AP, mean AP (MAP), and heart rate (HR) during injections
of substances into the brain stem, as described
previously.4 Briefly,
cannulas were inserted into a femoral artery and a femoral vein. The
trachea was cannulated, and the rat was connected to a ventilator. The
rat was placed into a stereotaxic instrument, and the
dorsal surface of the medulla was surgically exposed. After all surgery
was completed, the rat was injected with
-chloralose (60 mg/kg IV),
and the halothane was terminated. Additional chloralose (20 mg/kg IV)
was administered hourly. Rats were injected with tubocurarine (0.5
mg/kg, supplemented hourly with 0.2 mg/kg) and ventilated with 100%
oxygen for the remainder of the experiment. Injections of solutions
into the brain stem were made using single-barrel glass micropipettes.
All injections were in a volume of 100 nL of artificial cerebrospinal
fluid vehicle administered during 3 to 7 seconds using a PicoPump
(WPI). KYN was initially dissolved in 200 mmol/L sodium
bicarbonate and then diluted in artificial cerebrospinal fluid.
Bilateral injections were made one side at a time, with
30 seconds
separating the 2 injections. Coordinates for injections into the RVLM
were, with the pipette tip angled 20 degrees rostrally, 1.8 mm
rostral to the caudal tip of the area postrema, 1.8 mm lateral to
the midline, and 2.9 mm below the dorsal surface of the brain
stem. In each rat, initial test injections of 1 nmol of L-glutamate in
100 nL were made into the RVLM on each side to confirm that the
coordinates identified a functional pressor site. After identification
of functional pressor sites in the RVLM bilaterally, baseline MAP and
HR were recorded for at least 30 minutes, and then KYN (2.7 nmol)
was injected bilaterally into the RVLM.
At the conclusion of the experiment in DS rats,
hexamethonium (20 mg/kg) was injected
intravenously to determine the effect of total autonomic
blockade on MAP. In both DS and DR rats,
20 nL of 1% Fast green dye
was injected into the RVLM for histological
verification of the center of the microinjection site. The brain stem
was removed, frozen, and cut in the transverse plane into 30-µm
sections. Sections were mounted onto microscope slides and examined by
light microscopy. All RVLM injection sites were located in the rostral
medulla, just ventral to the compact portion of nucleus ambiguus,
similar to the injection sites that we have published
previously.10
KYN, L-glutamate, and hexamethonium were purchased from Sigma Chemical Co; other drugs and chemicals were obtained from standard commercial suppliers.
Data are expressed as mean±SEM. Responses in DS and DR rats fed with a high- or low-salt diet were compared by 2-way ANOVA (strain X diet) with post-hoc t tests using commercially available software (Statistica).
| Results |
|---|
|
|
|---|
-chloralose, had
similar MAP whether they were fed a diet containing 0.3% NaCl or 8%
NaCl
(Table).
Injection of KYN (2.7 nmol) bilaterally into the RVLM had little effect
on MAP in DR rats fed either diet
(Figure 1), in agreement with previous studies in which KYN
was injected into the RVLM of normotensive
rats.2 3 4 5
DS rats had increased MAP compared with the DR rats, and this
difference was markedly exaggerated by consumption of the high-salt
diet
(Table).
In contrast to what was observed with the DR rats, injection of KYN
into the RVLM of DS rats resulted in a decrease in MAP
(Figures 1 and 2). Furthermore, the KYN-evoked decrease in MAP
was considerably greater in DS rats consuming the 8% NaCl diet
compared with the 0.3% NaCl diet
(Figures 1 and 2). The KYN-evoked decrease in MAP in DS rats
began rapidly after the injection of KYN
(Figure 2) and persisted for many minutes. In DS rats fed the
8% NaCl diet, MAP began to decrease within 15 seconds of the bilateral
injection of KYN, although the latency to the maximal decrease in MAP
was 13±4 minutes; the duration of the response (defined as the time it
took for MAP to return to preinjection baseline) was 48±3 minutes. The
effects of injection of KYN into the RVLM on HR showed a similar
pattern of responses across the 4 groups of rats
(Figure 2 legend).
|
|
|
So that the KYN-evoked decrease in MAP in DS rats could be analyzed relative to the total extent to which the autonomic nervous system supports MAP, at the end of the experiment, DS rats were injected intravenously with hexamethonium (20 mg/kg). In DS rats consuming the 0.3% salt diet, hexamethonium decreased MAP by 58±4 mm Hg, whereas MAP decreased by 99±4 mm Hg in DS rats consuming the 8.0% NaCl diet. Thus, KYN reduced MAP by 27±4% of the decrease in MAP elicited by autonomic blockade in DS rats on the 0.3% NaCl diet, compared with a 39±3 decrease in DS rats on the high-salt diet (P<0.05).
Effects of Glutamate Injection into
RVLM
Glutamate (1 nmol) injected unilaterally into the RVLM
increased MAP in both DS and DR rats. However, the magnitude of the
response varied depending on the rat strain and the salt content of the
diet
(Figure 3). In DR rats, the increase in MAP was
100%
greater in rats fed the high-salt diet compared with rats fed the
low-salt diet
(Figure 2), although baseline MAP did not differ between
these groups. The glutamate-evoked increase in MAP was greater in DS
rats than in DR rats on either diet, although the salt content of the
diet did not influence the response in DS rats. Injection of glutamate
into the RVLM produced a decrease in HR that was larger in DS rats than
in DR rats, and it was enhanced by increased dietary salt intake in
only DR rats
(Figure 3 legend).
|
| Discussion |
|---|
|
|
|---|
Differences in the Response to Glutamate
Injected into the RVLM in DS and DR Rats
In comparing the pressor response to injection of
glutamate injected into the RVLM in DS and DR rats, 2 differences were
noted. First, the magnitude of the pressor response was greater in DS
rats compared with DR rats. Although simply comparing evoked pressor
responses between DR and DS rats is complicated by differing baseline
MAP, the difference in baseline MAP does not seem to explain an
increased pressor response to glutamate injected into the RVLM in the
DS rats. Baseline MAP are not very different between DS and DR rats
consuming the 0.3% NaCl diet, whereas the pressor responses are quite
different. Additionally, the potentiated response in DS rats is still
apparent when data are expressed as percent change from baseline.
Another factor complicating interpretation of the larger
glutamate-evoked pressor responses observed in the DS rats is the
differing vascular sensitivity to pressor substances that has been
reported in DS
rats.4 9 11 12
However, this factor does not seem to fully account for the current
results.
Although previous reports noted greater pressor responses to the intravenous injection of vasoconstrictor substances in DS compared with DR rats, the magnitude of this enhanced response is typically in the range of 50% to 100%, whereas in the present study the difference between DS and DR rats was substantially larger (eg, >300% with the 0.3% NaCl diet). Furthermore, in previous studies, the difference in pressor responses to vasoconstrictor substances between DS and DR rats is essentially eliminated by expressing evoked changes in MAP as a percent of baseline MAP,11 whereas in the present study, the increased pressor response to glutamate injected into the RVLM was still noted when data are expressed in this manner. Thus, it seems that the greater pressor response in DS rats compared with DR rats evoked by the injection of 1 nmol of glutamate into the RVLM reflects a difference in the neural control of the circulation, although the present data do not address whether this difference results from differences at the level of the RVLM or distal to it. Also, since the present study used only a single dose of glutamate, these data do not address whether the difference reflects an increased sensitivity to glutamate or enhanced maximal responsiveness (ie, whether in DS rats the dose-response curve is shifted to the left or rather shifted up).
Another complicating factor in comparing the responses evoked by the injection of glutamate into the RVLM of these 2 rat strains is the precise localization of the injection site. Although the microinjection coordinates were similar across all groups in the present study and the histological location of injection sites appeared similar, the anatomical location of pressor sites in the RVLM has not been extensively mapped in these 2 distinct rat strains. However, the use of a rather large injection volume (100 nL) and a rather large dose of glutamate (1 nmol) should obscure any slight difference in the anatomical location of RVLM pressor sites between DS and DR rats. Even so, it should be noted that the maximal increase in MAP with the injection of 1 nmol of glutamate into the RVLM in DR rats is less than that in other strains of normotensive rats.4 8
A second difference in the pressor response to glutamate injected into the RVLM between DS and DR rats relates to the effects of dietary salt on this response. In DR rats, the increase in MAP evoked by the injection of glutamate into the RVLM was potentiated by the high-salt diet. We observed this previously with normotensive Sprague-Dawley rats8 ; indeed, the magnitude of the effect of the high-salt diet is similar to what we reported previously in Sprague-Dawley rats. In contrast, increased dietary salt intake in DS rats did not alter the glutamate-evoked pressor response. Tsuchihashi et al13 previously reported similar data in DS rats, additionally noting that pressor responses were also similar in DS rats fed diets containing 0.3% and 8.0% NaCl when tested with smaller doses of glutamate and other EAA, indicating that our results cannot be explained simply by us having reached a maximum of how high MAP can increase. In addition, Tsuchihashi et al13 demonstrated that these similar pressor responses were accompanied by similar increases in sympathetic nerve activity, suggesting that the similar increases in MAP were not confounded by the large differences in baseline vasoconstrictor tone. However, this interpretation of the data is complicated by potential effects of dietary salt intake on baseline sympathetic nerve activity in DS rats.11 14
Taken together, these results suggest that the stimulation
of EAA receptors in the RVLM elicits a larger pressor response in DS
rats compared with DR rats and that, unlike DR rats and other
normotensive Sprague-Dawley rat strains, this response is not enhanced
by increased dietary salt intake in DS rats. However, it must be noted
that the pressor response to glutamate injected into the RVLM is based
on direct excitation of RVLM vasomotor neurons and the excitation of
indirectly-mediated inhibitory influences. The importance
of this indirect inhibitory influence to the overall
response to glutamate injected into the RVLM is supported by our
previous observation that after unilateral inhibition of the caudal
ventrolateral medulla, the site of most inhibitory input to
the RVLM, the response to glutamate injected into the RVLM was
substantially enhanced.4
Because increased dietary salt intake potentiates the depressor effects
of
-aminobutyric acid injected into the RVLM (Madden and Sved,
unpublished observations, 2000) as well as the pressor effects
of glutamate injected into the RVLM, the overall responsiveness to
glutamate injected into the RVLM of DS rats fed a high-salt diet
reflects the net effect of increased dietary salt on potentiating both
excitatory and inhibitory influences.
Differences in the Response to KYN Injected
into the RVLM in DS and DR Rats
KYN injected bilaterally into the RVLM of
anesthetized normotensive rats has been previously reported to
have little effect on
MAP2 3 4 5
and, in this regard, DR rats are no different. In contrast, KYN
significantly decreased MAP in DS rats, even when they were fed a
low-salt diet so their MAP was in a normotensive range. However, it
needs to be noted that even on a low-salt diet, baseline MAP in DS rats
is higher than that in DR rats, as amply documented in the
literature.9 The decrease in
MAP caused by KYN injection into the RVLM of DS rats was markedly
greater when dietary salt intake was increased, making them
hypertensive. Even when expressed as a percent of baseline MAP or a
percent of maximal decrease in MAP produced by autonomic blockade, the
KYN-induced decrease in MAP was greater in DS rats consuming the 8.0%
NaCl diet compared with DS rats consuming the 0.3% NaCl diet. The
observation that KYN injected into the RVLM of DS rats decreased MAP
suggests that tonically active EAA inputs to the RVLM act to support
MAP in this strain. This is different than what has been reported in
normotensive rat strains but similar to what has been reported in 2
experimental models of hypertension in rats (spontaneously hypertensive
rats5 and renal hypertensive
rats6 ).
Incorporation of These Results in Dahl Rats
into a Model of RVLM Control of Blood Pressure
In DR rats, like in other normotensive rats, injection
of KYN into the RVLM has little effect on MAP. We previously suggested
that this is due to a precise balance between tonically active
EAA-mediated inputs to the RVLM that directly excite and those that
indirectly inhibit RVLM vasomotor outflow. Placing normotensive rats on
diet with a very high salt content does not increase MAP, although it
does increase responsiveness to excitatory and inhibitory
influences on the RVLM. Apparently, the excitatory and
inhibitory influences on the RVLM remain in balance, and
the lack of an effect of KYN in DR rats, despite an increase in
glutamate-evoked pressor responses, provides evidence to support this
notion.
In contrast, in 3 different models of experimental hypertension (DS rats, spontaneously hypertensive rats, and renal hypertensive rats), KYN injected into the RVLM decreases MAP.5 6 This could be explained by the balance of excitatory and inhibitory influences in the RVLM driven by tonically active EAA inputs to this region being shifted toward excitation. The present data suggest that in the case of the DS rat consuming a diet with a relatively low salt content, resulting in rather normotensive levels of MAP, there is an underlying imbalance between these influences. Placing DS rats on a high-salt diet magnifies this imbalance; therefore, baseline MAP is increased and falls to a greater extent when KYN is injected into the RVLM.
Interestingly, increasing the salt content of the diet does not increase the pressor response evoked by EAA injected into the RVLM in DS rats as it does in other rat strains. Thus, the hypertension observed in DS rats fed a high-salt diet cannot simply be explained by salt-evoked increased responsiveness to EAA in the RVLM. Possibly, an altered potentiation of EAA-mediated inhibition and excitation of the RVLM could explain these data; additional studies are needed to examine this issue.
This model would also predict that in other models of experimental hypertension in which there is an underlying imbalance between excitatory and inhibitory influences in the RVLM, the hypertension should be exaggerated by increased dietary salt intake. Interestingly, the 2 other experimental models of hypertension in which KYN injected into the RVLM has been found to decrease MAP are known to be exacerbated by increased dietary salt.15
Conclusions
In summary, the present data demonstrate an
abnormal regulation of MAP in DS rats mediated by EAA in the RVLM. The
data are consistent with the hypothesis that hypertension in
the DS rat is due to an imbalance of the excitatory and
inhibitory influences of EAA-mediated inputs to the RVLM,
and this imbalance is magnified by increased dietary
salt.
| Acknowledgments |
|---|
Received October 25, 2000; first decision November 30, 2000; accepted December 18, 2000.
| References |
|---|
|
|
|---|
2.
Kiely JM, Gordon
FJ. Role of rostral ventrolateral medulla in centrally mediated pressor
responses. Am J Physiol. 1994;267:H1549H1556.
3.
Sun MK, Guyenet PG.
Hypothalamic glutamatergic input to medullary
sympathoexcitatory neurons in rats.
Am J Physiol. 1986;251:R798R810.
4.
Ito S, Sved AF.
Tonic glutamate-mediated control of rostral ventrorateral medulla and
sympathetic vasomotor tone. Am J
Physiol. 1997;273:R487R494.
5.
Ito S, Komatsu K,
Tsukamoto K, Sved AF. Excitatory amino acids in rostral ventrolateral
medulla support blood pressure in spontaneously hypertensive rats.
Hypertension. 2000;35:413417.
6.
Bergamaschi C,
Campos RR, Schor N, Lopes OU. Role of the rostral ventrolateral medulla
in maintenance of blood pressure in rats with Goldblatt
hypertension. Hypertension. 1995;26:11171120.
7.
Pawloski-Dahm CM,
Gordon FJ. Increased dietary salt sensitizes vasomotor neurons of
the rostral ventrolateral medulla.
Hypertension. 1993;22:929933.
8. Ito S, Gordon FJ, Sved AF. Dietary salt intake alters cardiovascular responses evoked from the rostral ventrolateral medulla. Am J Physiol. 1999;276:R1600R1607.
9.
Rapp JP. Dahl
salt-susceptible and salt-resistant rats.
Hypertension,. 1982;4:753763.
10.
Ito S, Sved AF.
Blockade of angiotensin receptors in rat rostral
ventrolateral medulla removes excitatory vasomotor tone.
Am J Physiol. 1996;270:R1317R1323.
11.
Bunag RD,
Butterfield J, Sasaki S. Hypothalamic pressor responses and
salt-induced hypertension in Dahl rats.
Hypertension. 1983;5:460467.
12. Gordon FJ. Matsuguchi H, Mark AL. Abnormal baroreflex control of heart rate in prehypertensive and hypertensive Dahl genetically salt-sensitive rats. Hypertension. 1981;3(suppl I):I-135I-141.
13. Tsuchihashi T, Kagiyama S, Onaka U, Abe I, Fujishima M. Pressor and sympathetic response to excitatory amino acids are not augmented in the ventrolateral medulla of Dahl salt-sensitive rats. Brain Res. 1997;750:195200.[Medline] [Order article via Infotrieve]
14. Mark AL. Sympathetic neural contribution to salt-induced hypertension in Dahl rats. Hypertension. 1991;17:8690.
15. Oparil S, Chen YF, Yang RH, Meng JQC, Wyss JM. The neuronal basis of salt sensitivity. In Retting R, Ganten D, and Luft FC, eds. Salt and Hypertension. Berlin: Springer Verlag; 1989:83p96.
This article has been cited by other articles:
![]() |
J. M. Adams, M. E. Bardgett, and S. D. Stocker Ventral Lamina Terminalis Mediates Enhanced Cardiovascular Responses of Rostral Ventrolateral Medulla Neurons During Increased Dietary Salt Hypertension, August 1, 2009; 54(2): 308 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-Z. Wang, L. Gao, H.-J. Wang, I. H. Zucker, and W. Wang Tonic Glutamatergic Input in the Rostral Ventrolateral Medulla Is Increased in Rats With Chronic Heart Failure Hypertension, February 1, 2009; 53(2): 370 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Sved Tonic glutamatergic drive of RVLM vasomotor neurons? Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1301 - R1303. [Full Text] [PDF] |
||||
![]() |
J. Horiuchi, S. Killinger, and R. A. L. Dampney Contribution to sympathetic vasomotor tone of tonic glutamatergic inputs to neurons in the RVLM Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1335 - R1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Brooks, K. L. Freeman, and T. L. O'Donaughy Acute and chronic increases in osmolality increase excitatory amino acid drive of the rostral ventrolateral medulla in rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1359 - R1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Brooks, K. L. Freeman, and K. A. Clow Excitatory amino acids in rostral ventrolateral medulla support blood pressure during water deprivation in rats Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1642 - H1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ito, M. Hiratsuka, K. Komatsu, K. Tsukamoto, K. Kanmatsuse, and A. F. Sved Ventrolateral Medulla AT1 Receptors Support Arterial Pressure in Dahl Salt-Sensitive Rats Hypertension, March 1, 2003; 41(3): 744 - 750. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |